Xian Zhang

Xian Zhang

Auto-generated profile, based on publicly available information

Xian Zhang

School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2022 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
ZZZhixin Zhang
Zhixin Zhang
JWJiahui Wang
Jiahui Wang
YLYan Lin
Yan Lin
JCJuan Chen
Juan Chen
JLJian Liu
Jian Liu
XZXian Zhang
Xian Zhang
Obesity is characterized by excessive body fat accumulation and is a high-risk factor for metabolic comorbidities, including type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular disease. In lean individuals, adipose tissue (AT) is not only an important regulatory organ for energy storage and metabolism, but also an indispensable immune and endocrine organ. The sustained energy imbalance induces adipocyte hypotrophy and hyperplasia as well as AT remodeling, accompanied by chronic low-grade inflammation and adipocytes dysfunction in AT, ultimately leading to systemic insulin resistance and ectopic lipid deposition. Luteolin is a natural flavonoid widely distributed in fruits and vegetables and possesses multifold biological activities, such as antioxidant, anticancer, and anti-inflammatory activities. Diet supplementation of this flavonoid has been reported to inhibit AT lipogenesis and inflammation as well as the ectopic lipid deposition, increase AT thermogenesis and systemic energy expenditure, and finally improve obesity and associated metabolic diseases. The purpose of this review is to reveal the nutritional activities of luteolin in obesity and its complications with emphasis on its action on AT energy metabolism, immunoregulation, and endocrine intervention.

1 February 2019 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
WFWenqian Fang
Wenqian Fang
AHAina He
Aina He
MXMei-Xiang Xiang
Mei-Xiang Xiang
YLYan Lin
Yan Lin
YWYajun Wang
Yajun Wang
GSGuo-Ping Shi
Guo-Ping Shi

8 April 2022 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
CYChongzhe Yang
Chongzhe Yang
JLJie Li
Jie Li
ZDZhiyong Deng
Zhiyong Deng
SLSongyuan Luo
Songyuan Luo
JLJing Liu
Jing Liu
GSGuo-Ping Shi
Guo-Ping Shi
Aims: Blood eosinophil (EOS) counts and EOS cationic protein (ECP) levels associate positively with major cardiovascular disease (CVD) risk factors and prevalence. This study investigates the role of EOS in cardiac hypertrophy.Methods and results: A retrospective cross-section study of 644 consecutive inpatients with hypertension examined the association between blood EOS counts and cardiac hypertrophy. Pressure overload- and β-adrenoreceptor agonist isoproterenol-induced cardiac hypertrophy was produced in EOS-deficient ΔdblGATA mice. This study revealed positive correlations between blood EOS counts and left ventricular (LV) mass and mass index in humans. ΔdblGATA mice showed exacerbated cardiac hypertrophy and dysfunction, with increased LV wall thickness, reduced LV internal diameter, and increased myocardial cell size, death, and fibrosis. Repopulation of EOS from wild-type (WT) mice, but not those from IL4-deficient mice ameliorated cardiac hypertrophy and cardiac dysfunctions. In ΔdblGATA and WT mice, administration of ECP mEar1 improved cardiac hypertrophy and function. Mechanistic studies demonstrated that EOS expression of IL4, IL13, and mEar1 was essential to control mouse cardiomyocyte hypertrophy and death and cardiac fibroblast TGF-β signalling and fibrotic protein synthesis. The use of human cardiac cells yielded the same results. Human ECP, EOS-derived neurotoxin, human EOS, or murine recombinant mEar1 reduced human cardiomyocyte death and hypertrophy and human cardiac fibroblast TGF-β signalling.Conclusion: Although blood EOS counts correlated positively with LV mass or LV mass index in humans, this study established a cardioprotective role for EOS IL4 and cationic proteins in cardiac hypertrophy and tested a therapeutic possibility of ECPs in this human CVD.

9 November 2022 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
LZLingli Zhao
Lingli Zhao
MZMengfei Zheng
Mengfei Zheng
HCHao Cai
Hao Cai
JCJuan Chen
Juan Chen
YLYan Lin
Yan Lin
JLJian Liu
Jian Liu

17 March 2023 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
JWJiahui Wang
Jiahui Wang
ZZZhixin Zhang
Zhixin Zhang
YLYan Lin
Yan Lin
JCJuan Chen
Juan Chen
FWFangbin Wang
Fangbin Wang
XZXian Zhang
Xian Zhang

24 February 2023 in STAR Protocols
Verified
Journal Article
Open access
HCHao Chen
Hao Chen
JLJian Liu
Jian Liu
GSGuo-Ping Shi
Guo-Ping Shi
XZXian Zhang
Xian Zhang
Mouse hyperglycemia model and islet function assessment are essential in diabetes research. Here, we provide a protocol to evaluate glucose homeostasis and islet functions in diabetic mice and isolated islets. We describe steps for establishing type 1 and 2 diabetes, glucose tolerance test, insulin tolerance test, glucose stimulated insulin secretion (GSIS) assay, and histological analysis for islet number and insulin expression in vivo. We then detail islet isolation, islet GSIS, β-cell proliferation, apoptosis, and programming assays ex vivo. For complete details on the use and execution of this protocol, please refer to Zhang et al. (2022).1.